TABLE OF CONTENTS
1 INTRODUCTION 28
1.1 OBJECTIVES OF THE STUDY 28
1.2 MARKET DEFINITION 28
1.3 OVERVIEW OF MIDDLE EAST & AFRICA MEDICAL IMAGING (3D AND 4D) SOFTWARE MARKET 28
1.4 CURRENCY AND PRICING 30
1.5 LIMITATIONS 30
1.6 MARKETS COVERED 31
2 MARKET SEGMENTATION 33
2.1 MARKETS COVERED 33
2.2 GEOGRAPHICAL SCOPE 34
2.3 YEARS CONSIDERED FOR THE STUDY 35
2.4 DBMR TRIPOD DATA VALIDATION MODEL 36
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 39
2.6 MULTIVARIATE MODELLING 40
2.7 MARKET APPLICATION COVERAGE GRID 41
2.8 PRODUCT TYPE LIFELINE CURVE 42
2.9 DBMR MARKET POSITION GRID 43
2.10 VENDOR SHARE ANALYSIS 44
2.11 SECONDARY SOURCES 45
2.12 ASSUMPTIONS 45
3 EXECUTIVE SUMMARY 46
3.1 PESTEL_ANALYSIS 51
3.2 PORTER'S FIVE FORCES MODEL 52
4 INDUSTRIAL INSIGHTS: 53
5 MARKET OVERVIEW 55
5.1 DRIVERS 57
5.1.1 TECHNOLOGICAL ADVANCEMENT LEADING TO NEW PRODUCT LAUNCH 57
5.1.2 INCREASE IN PUBLIC-PRIVATE FUNDING 57
5.1.3 HEAVY INVESTMENTS FOR R&D ACTIVITIES RELATED TO IMAGING SOFTWARE 57
5.1.4 RISE IN APPLICATIONS OF IMAGING SOFTWARE IN THE HEALTHCARE INDUSTRY 58
5.2 RESTRAINTS 58
5.2.1 HIGH COSTS OF IMAGING EQUIPMENT 58
5.2.2 LACK OF TECHNICAL EXPERTISE 58
5.2.3 STRINGENT RULES & REGULATIONS FOR PRODUCT APPROVAL 59

5.3 OPPORTUNITIES 59
5.3.1 RISE IN GERIATRIC POPULATION 59
5.3.2 INCREASED DISPOSABLE INCOME ACROSS THE GLOBE 60
5.3.3 CLOUD-BASED IMAGE ANALYSIS SOFTWARE 60
5.4 CHALLENGES 61
5.4.1 LESS ADOPTION OF MEDICAL IMAGING SOFTWARE IN DEVELOPING COUNTRIES 61
5.4.2 HACKING-RELATED RISKS ASSOCIATED WITH THE USE OF IMAGING EQUIPMENT AND SOFTWARE 61
6 MIDDLE EAST & AFRICA MEDICAL IMAGING (3D AND 4D) SOFTWARE MARKET, BY TYPE 62
6.1 OVERVIEW 63
6.2 INTEGRATED SOFTWARE 66
6.3 STANDALONE SOFTWARE 66
7 MIDDLE EAST & AFRICA MEDICAL IMAGING (3D AND 4D) SOFTWARE MARKET, BY IMAGE TYPE 68
7.1 OVERVIEW 69
7.2 3D IMAGING 72
7.3 4D IMAGING 72
8 MIDDLE EAST & AFRICA MEDICAL IMAGING (3D AND 4D) SOFTWARE MARKET, BY MODALITY 74
8.1 OVERVIEW 75
8.2 RADIOGRAPHIC IMAGING 78
8.3 ULTRASOUND IMAGING 78
8.3.1 3D/4D ULTRASOUND IMAGING 79
8.3.2 DOPPLER IMAGING 79
8.4 COMBINED MODALITIES 79
8.4.1 PET/CT 80
8.4.2 SPECT/CT 80
8.4.3 PET/MR 81
8.5 TRAUMATIC BRAIN INJURY (TBI) 81
8.5.1 COMPUTED TOMOGRAPHY (CT) 82
8.5.2 MAGNETIC RESONANCE IMAGING (MRI) 82
8.5.3 POSITRON EMISSION TOMOGRAPHY (PET) 82
8.5.4 SINGLE-PHOTON EMISSION COMPUTED TOMOGRAPHY (SPECT) 82

9 MIDDLE EAST & AFRICA MEDICAL IMAGING (3D AND 4D) SOFTWARE MARKET, BY APPLICATION 83
9.1 OVERVIEW 84
9.2 ORTHOPEDICS 88
9.3 ONCOLOGY 88
9.4 MAMMOGRAPHY 89
9.5 RESPIRATORY APPLICATIONS 90
9.6 CARDIOLOGY 91
9.7 OBSTETRICS AND GYNECOLOGY 92
9.8 NEUROLOGY 92
9.9 UROLOGY AND NEPHROLOGY 93
9.10 DENTAL APPLICATION 94
9.11 OTHERS 94
10 MIDDLE EAST & AFRICA MEDICAL IMAGING (3D AND 4D) SOFTWARE MARKET, BY END USER 96
10.1 OVERVIEW 97
10.2 HOSPITALS 100
10.3 DIAGNOSTIC CENTERS 100
10.4 RESEARCH CENTERS 101
10.5 OTHERS 102
11 MIDDLE EAST & AFRICA MEDICAL IMAGING (3D AND 4D) SOFTWARE MARKET, BY REGION 104
11.1 MIDDLE EAST AND AFRICA 105
11.1.1 U.A.E 112
11.1.2 SAUDI ARABIA 114
11.1.3 EGYPT 116
11.1.4 SOUTH AFRICA 118
11.1.5 ISRAEL 120
11.1.6 REST OF MIDDLE EAST AND AFRICA 122
12 MIDDLE EAST & AFRICA MEDICAL IMAGING (3D AND 4D) SOFTWARE MARKET, COMPANY LANDSCAPE 123
12.1 COMPANY SHARE ANALYSIS: MIDDLE EAST & AFRICA 123
13 SWOT ANALYSIS 124

14 COMPANY PROFILE 125
14.1 GENERAL ELECTRIC 125
14.1.1 COMPANY SNAPSHOT 125
14.1.2 REVENUE ANALYSIS 125
14.1.3 COMPANY SHARE ANALYSIS 126
14.1.4 PRODUCT PORTFOLIO 126
14.1.5 RECENT DEVELOPMENTS 127
14.2 SYNOPSYS, INC. 128
14.2.1 COMPANY SNAPSHOT 128
14.2.2 REVENUE ANALYSIS 128
14.2.3 COMPANY SHARE ANALYSIS 129
14.2.4 PRODUCT PORTFOLIO 129
14.2.5 RECENT DEVELOPMENTS 130
14.3 CARESTREAM DENTAL LLC 131
14.3.1 COMPANY SNAPSHOT 131
14.3.2 COMPANY SHARE ANALYSIS 131
14.3.3 PRODUCT PORTFOLIO 131
14.3.4 RECENT DEVELOPMENT 132
14.4 KONINKLIJKE PHILIPS N.V., 133
14.4.1 COMPANY SNAPSHOT 133
14.4.2 REVENUE ANALYSIS 133
14.4.3 COMPANY SHARE ANALYSIS 134
14.4.4 PRODUCT PORTFOLIO 134
14.4.5 RECENT DEVELOPMENTS 135
14.5 SIEMENS HEALTHCARE GMBH 136
14.5.1 COMPANY SNAPSHOT 136
14.5.2 REVENUE ANALYSIS 136
14.5.3 COMPANY SHARE ANALYSIS 137
14.5.4 PRODUCT PORTFOLIO 137
14.5.5 RECENT DEVELOPMENTS 138
14.6 AIDOC 139
14.6.1 COMPANY SNAPSHOT 139
14.6.2 PRODUCT PORTFOLIO 139
14.6.3 RECENT DEVELOPMENTS 140
14.7 ALPINION MEDICAL SYSTEMS CO., LTD. 141
14.7.1 COMPANY SNAPSHOT 141
14.7.2 PRODUCT PORTFOLIO 141
14.7.3 RECENT DEVELOPMENT 141

14.8 ARTERYS INC. 142
14.8.1 COMPANY SNAPSHOT 142
14.8.2 PRODUCT PORTFOLIO 142
14.8.3 RECENT DEVELOPMENTS 143
14.9 CONTEXTVISION AB (PUBL) 144
14.9.1 COMPANY SNAPSHOT 144
14.9.2 REVENUE ANALYSIS 144
14.9.3 PRODUCT PORTFOLIO 145
14.9.4 RECENT DEVELOPMENT 145
14.10 EFFECTIVESOFT 146
14.10.1 COMPANY SNAPSHOT 146
14.10.2 PRODUCT PORTFOLIO 146
14.10.3 RECENT DEVELOPMENTS 146
14.11 ESAOTE SPA 147
14.11.1 COMPANY SNAPSHOT 147
14.11.2 PRODUCT PORTFOLIO 147
14.11.3 RECENT DEVELOPMENT 147
14.12 FUJIFILM VISUALSONICS, INC. (A SUBSIDIARY OF FUJIFILM) 148
14.12.1 COMPANY SNAPSHOT 148
14.12.2 PRODUCT PORTFOLIO 148
14.12.3 RECENT DEVELOPMENT 149
14.13 INFINITT HEALTHCARE CO. LTD 150
14.13.1 COMPANY SNAPSHOT 150
14.13.2 PRODUCT PORTFOLIO 150
14.13.3 RECENT DEVELOPMENT 150
14.14 MATERIALISE 151
14.14.1 COMPANY SNAPSHOT 151
14.14.2 REVENUE ANALYSIS 151
14.14.3 PRODUCT PORTFOLIO 152
14.15 MIM SOFTWARE INC. 153
14.15.1 COMPANY SNAPSHOT 153
14.15.2 PRODUCT PORTFOLIO 153
14.15.3 RECENT DEVELOPMENTS 153
14.16 MIRADA MEDICAL LIMITED 154
14.16.1 COMPANY SNAPSHOT 154
14.16.2 PRODUCT PORTFOLIO 154
14.16.3 RECENT DEVELOPMENTS 154

14.17 PIE MEDICAL IMAGING B.V. 155
14.17.1 COMPANY SNAPSHOT 155
14.17.2 PRODUCT PORTFOLIO 155
14.17.3 RECENT DEVELOPMENTS 155
14.18 QMENTA 156
14.18.1 COMPANY SNAPSHOT 156
14.18.2 PRODUCT PORTFOLIO 156
14.18.3 RECENT DEVELOPMENTS 156
14.19 SCIENCESOFT USA CORPORATION 157
14.19.1 COMPANY SNAPSHOT 157
14.19.2 PRODUCT PORTFOLIO 157
14.19.3 RECENT DEVELOPMENT 157
14.20 XINAPSE SYSTEMS LTD 158
14.20.1 COMPANY SNAPSHOT 158
14.20.2 PRODUCT PORTFOLIO 158
14.20.3 RECENT DEVELOPMENTS 158
15 QUESTIONNAIRE 159
16 RELATED REPORTS 162

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.